Universal Electronics Reports Financial Results for the Third Quarter 2020
Nov 5, 2020
|
- Guides for Record Profitability in Q4 2020 -
-
“Our strategies to develop differentiated advanced products, license technology, expand our margins and improve our profitability continue to successfully build upon our foundation for sustainable growth,” said
Financial Results for the Three Months Ended
- GAAP net sales were
$153.5 million , compared to$200.7 million ; Adjusted Non-GAAP net sales were$153.7 million , compared to$200.9 million . - GAAP gross margins were 28.8%, compared to 23.2%; Adjusted Non-GAAP gross margins were 30.0%, compared to 26.8%.
- GAAP operating income was
$10.2 million , compared to$6.1 million ; Adjusted Non-GAAP operating income was$17.0 million , compared to$18.7 million . - GAAP net income was
$6.2 million , or$0.43 per diluted share, compared to$2.7 million or$0.19 per share; Adjusted Non-GAAP net income was$13.1 million , or$0.92 per diluted share, compared to$14.3 million , or$1.01 per diluted share. - At
September 30, 2020 , cash and cash equivalents were$67.1 million .
Financial Results for the Nine Months Ended
- GAAP net sales were
$458.4 million , compared to$578.8 million ; Adjusted Non-GAAP net sales were$458.9 million , compared to$577.0 million . - GAAP gross margins were 27.3%, compared to 20.8%; Adjusted Non-GAAP gross margins were 29.8%, compared to 26.0%.
- GAAP operating income was
$24.8 million , compared to$3.9 million ; Adjusted Non-GAAP operating income was$46.5 million , compared to$49.1 million . - GAAP net income was
$26.4 million , or$1.86 per diluted share, compared to a net loss of$3.4 million or$0.25 per share; Adjusted Non-GAAP net income was$37.3 million , or$2.63 per diluted share, compared to$37.3 million , or$2.66 per diluted share.
Financial Outlook
For the fourth quarter of 2020, the company expects GAAP net sales to range between
For the fourth quarter of 2020, the company expects Adjusted Non-GAAP net sales to range between
Conference Call Information
UEI’s management team will hold a conference call today,
Use of Non-GAAP Financial Metrics
In addition to reporting financial results in accordance with generally accepted accounting principles, or GAAP, UEI provides Adjusted Non-GAAP information as additional information for its operating results. References to Adjusted Non-GAAP information are to non-GAAP financial measures. These measures are not required by, in accordance with, or an alternative for, GAAP and may be different from non-GAAP financial measures used by other companies. UEI’s management uses these measures for reviewing the financial results of UEI, for budget planning purposes, and for making operational and financial decisions and believes that providing these non-GAAP financial measures to investors, as a supplement to GAAP financial measures, help investors evaluate UEI’s core operating and financial performance and business trends consistent with how management evaluates such performance and trends. Additionally, management believes these measures facilitate comparisons with the core operating and financial results and business trends of competitors and other companies.
Adjusted Non-GAAP net sales is defined as net sales excluding the revenue impact of the additional Section 301 U.S. tariffs on products manufactured in
About
Founded in 1986,
Forward-looking Statements
This press release and accompanying schedules contain "forward-looking statements" within the meaning of federal securities laws, including net sales, profit margin and earnings trends, estimates and assumptions; our expectations about new product introductions; and similar statements concerning anticipated future events and expectations that are not historical facts. We caution you that these statements are not guarantees of future performance and are subject to numerous risks and uncertainties, including those we identify below and other risk factors that we identify in our most recent annual report on Form 10-K and other reports we have filed with the
– Tables Follow –
|
||||||||
|
|
|
|
|
||||
ASSETS |
|
|
|
|
||||
Current assets: |
|
|
|
|
||||
Cash and cash equivalents |
|
$ |
67,146 |
|
|
$ |
74,302 |
|
Accounts receivable, net |
|
128,094 |
|
|
139,198 |
|
||
Contract assets |
|
11,530 |
|
|
12,579 |
|
||
Inventories |
|
115,750 |
|
|
145,135 |
|
||
Prepaid expenses and other current assets |
|
5,768 |
|
|
6,733 |
|
||
Income tax receivable |
|
1,536 |
|
|
805 |
|
||
Total current assets |
|
329,824 |
|
|
378,752 |
|
||
Property, plant and equipment, net |
|
84,549 |
|
|
90,732 |
|
||
|
|
48,526 |
|
|
48,447 |
|
||
Intangible assets, net |
|
19,617 |
|
|
19,830 |
|
||
Operating lease right-of-use assets |
|
18,678 |
|
|
19,826 |
|
||
Deferred income taxes |
|
4,581 |
|
|
4,409 |
|
||
Other assets |
|
2,842 |
|
|
2,163 |
|
||
Total assets |
|
$ |
508,617 |
|
|
$ |
564,159 |
|
LIABILITIES AND STOCKHOLDERS’ EQUITY |
|
|
|
|
||||
Current liabilities: |
|
|
|
|
||||
Accounts payable |
|
$ |
67,546 |
|
|
$ |
102,588 |
|
Line of credit |
|
50,000 |
|
|
68,000 |
|
||
Accrued compensation |
|
22,890 |
|
|
43,668 |
|
||
Accrued sales discounts, rebates and royalties |
|
10,183 |
|
|
9,766 |
|
||
Accrued income taxes |
|
9,910 |
|
|
6,989 |
|
||
Other accrued liabilities |
|
33,616 |
|
|
35,445 |
|
||
Total current liabilities |
|
194,145 |
|
|
266,456 |
|
||
Long-term liabilities: |
|
|
|
|
||||
Operating lease obligations |
|
13,284 |
|
|
15,639 |
|
||
Contingent consideration |
|
250 |
|
|
4,349 |
|
||
Deferred income taxes |
|
2,327 |
|
|
1,703 |
|
||
Income tax payable |
|
1,368 |
|
|
1,600 |
|
||
Other long-term liabilities |
|
688 |
|
|
13 |
|
||
Total liabilities |
|
212,062 |
|
|
289,760 |
|
||
Commitments and contingencies |
|
|
|
|
||||
Stockholders’ equity: |
|
|
|
|
||||
Preferred stock, |
|
— |
|
|
— |
|
||
Common stock, |
|
243 |
|
|
241 |
|
||
Paid-in capital |
|
296,674 |
|
|
288,338 |
|
||
|
|
(287,639 |
) |
|
(277,817 |
) |
||
Accumulated other comprehensive income (loss) |
|
(25,555 |
) |
|
(22,781 |
) |
||
Retained earnings |
|
312,832 |
|
|
286,418 |
|
||
Total stockholders’ equity |
|
296,555 |
|
|
274,399 |
|
||
Total liabilities and stockholders’ equity |
|
$ |
508,617 |
|
|
$ |
564,159 |
|
|
||||||||||||||||
|
|
Three Months Ended |
|
Nine Months Ended |
||||||||||||
|
|
2020 |
|
2019 |
|
2020 |
|
2019 |
||||||||
Net sales |
|
$ |
153,505 |
|
|
$ |
200,724 |
|
|
$ |
458,416 |
|
|
$ |
578,783 |
|
Cost of sales |
|
109,349 |
|
|
154,245 |
|
|
333,244 |
|
|
458,437 |
|
||||
Gross profit |
|
44,156 |
|
|
46,479 |
|
|
125,172 |
|
|
120,346 |
|
||||
Research and development expenses |
|
7,696 |
|
|
7,930 |
|
|
22,979 |
|
|
21,884 |
|
||||
Selling, general and administrative expenses |
|
26,214 |
|
|
32,422 |
|
|
77,441 |
|
|
94,598 |
|
||||
Operating income |
|
10,246 |
|
|
6,127 |
|
|
24,752 |
|
|
3,864 |
|
||||
Interest income (expense), net |
|
(268 |
) |
|
(784 |
) |
|
(1,272 |
) |
|
(3,088 |
) |
||||
Accrued social insurance adjustment |
|
— |
|
|
— |
|
|
9,464 |
|
|
— |
|
||||
Other income (expense), net |
|
(1,646 |
) |
|
(148 |
) |
|
(1,263 |
) |
|
(426 |
) |
||||
Income before provision for income taxes |
|
8,332 |
|
|
5,195 |
|
|
31,681 |
|
|
350 |
|
||||
Provision for income taxes |
|
2,164 |
|
|
2,526 |
|
|
5,267 |
|
|
3,747 |
|
||||
Net income (loss) |
|
$ |
6,168 |
|
|
$ |
2,669 |
|
|
$ |
26,414 |
|
|
$ |
(3,397 |
) |
|
|
|
|
|
|
|
|
|
||||||||
Earnings (loss) per share: |
|
|
|
|
|
|
||||||||||
Basic |
|
$ |
0.44 |
|
|
$ |
0.19 |
|
|
$ |
1.90 |
|
|
$ |
(0.25 |
) |
Diluted |
|
$ |
0.43 |
|
|
$ |
0.19 |
|
|
$ |
1.86 |
|
|
$ |
(0.25 |
) |
Shares used in computing earnings (loss) per share: |
|
|
|
|
|
|
|
|
||||||||
Basic |
|
13,928 |
|
|
13,894 |
|
|
13,935 |
|
|
13,861 |
|
||||
Diluted |
|
14,205 |
|
|
14,170 |
|
|
14,189 |
|
|
13,861 |
|
|
||||||||
|
|
Nine Months Ended |
||||||
|
|
2020 |
|
2019 |
||||
Cash provided by (used for) operating activities: |
|
|
|
|
||||
Net income (loss) |
|
$ |
26,414 |
|
|
$ |
(3,397 |
) |
Adjustments to reconcile net income (loss) to net cash provided by (used for) operating activities: |
|
|
|
|
||||
Depreciation and amortization |
|
22,857 |
|
|
23,734 |
|
||
Provision for bad debts |
|
271 |
|
|
275 |
|
||
Deferred income taxes |
|
503 |
|
|
2,273 |
|
||
Shares issued for employee benefit plan |
|
959 |
|
|
876 |
|
||
Employee and director stock-based compensation |
|
6,854 |
|
|
6,718 |
|
||
Performance-based common stock warrants |
|
525 |
|
|
1,381 |
|
||
Impairment of long-term assets |
|
57 |
|
|
— |
|
||
Accrued social insurance adjustment |
|
(9,464 |
) |
|
— |
|
||
Loss on sale of |
|
712 |
|
|
— |
|
||
Changes in operating assets and liabilities: |
|
|
|
|
||||
Accounts receivable and contract assets |
|
11,556 |
|
|
(11,117 |
) |
||
Inventories |
|
30,466 |
|
|
4,403 |
|
||
Prepaid expenses and other assets |
|
601 |
|
|
5,507 |
|
||
Accounts payable and accrued liabilities |
|
(50,507 |
) |
|
11,686 |
|
||
Accrued income taxes |
|
2,023 |
|
|
(2,418 |
) |
||
Net cash provided by (used for) operating activities |
|
43,827 |
|
|
39,921 |
|
||
Cash provided by (used for) investing activities: |
|
|
|
|
||||
Acquisitions of property, plant and equipment |
|
(10,864 |
) |
|
(15,854 |
) |
||
Acquisitions of intangible assets |
|
(5,254 |
) |
|
(1,505 |
) |
||
Payment on sale of |
|
(500 |
) |
|
— |
|
||
Net cash provided by (used for) investing activities |
|
(16,618 |
) |
|
(17,359 |
) |
||
Cash provided by (used for) financing activities: |
|
|
|
|
||||
Borrowings under line of credit |
|
70,000 |
|
|
57,500 |
|
||
Repayments on line of credit |
|
(88,000 |
) |
|
(71,000 |
) |
||
Proceeds from stock options exercised |
|
— |
|
|
411 |
|
||
|
|
(9,822 |
) |
|
(1,741 |
) |
||
Contingent consideration payments in connection with business combinations |
|
(3,091 |
) |
|
(4,251 |
) |
||
Net cash provided by (used for) financing activities |
|
(30,913 |
) |
|
(19,081 |
) |
||
Effect of exchange rate changes on cash and cash equivalents |
|
(3,452 |
) |
|
(1,959 |
) |
||
Net increase (decrease) in cash and cash equivalents |
|
(7,156 |
) |
|
1,522 |
|
||
Cash and cash equivalents at beginning of period |
|
74,302 |
|
|
53,207 |
|
||
Cash and cash equivalents at end of period |
|
$ |
67,146 |
|
|
$ |
54,729 |
|
|
|
|
|
|
||||
Supplemental cash flow information: |
|
|
|
|
||||
Income taxes paid |
|
$ |
3,242 |
|
|
$ |
5,608 |
|
Interest paid |
|
$ |
1,404 |
|
|
$ |
3,479 |
|
|
||||||||||||||||
|
|
Three Months Ended |
|
Nine Months Ended |
||||||||||||
|
|
2020 |
|
2019 |
|
2020 |
|
2019 |
||||||||
Net sales: |
|
|
|
|
|
|
|
|
||||||||
Net sales - GAAP |
|
$ |
153,505 |
|
|
$ |
200,724 |
|
|
$ |
458,416 |
|
|
$ |
578,783 |
|
Section 301 U.S. tariffs on goods imported from |
|
— |
|
|
(549 |
) |
|
— |
|
|
(3,195 |
) |
||||
Stock-based compensation for performance-based warrants |
|
187 |
|
|
711 |
|
|
525 |
|
|
1,381 |
|
||||
Adjusted Non-GAAP net sales |
|
$ |
153,692 |
|
|
$ |
200,886 |
|
|
$ |
458,941 |
|
|
$ |
576,969 |
|
|
|
|
|
|
|
|
|
|
||||||||
Cost of sales: |
|
|
|
|
|
|
|
|
||||||||
Cost of sales - GAAP |
|
$ |
109,349 |
|
|
$ |
154,245 |
|
|
$ |
333,244 |
|
|
$ |
458,437 |
|
Section 301 U.S. tariffs on goods imported from |
|
— |
|
|
(3,954 |
) |
|
(3,523 |
) |
|
(14,461 |
) |
||||
Excess manufacturing overhead and factory transition costs (2) |
|
(1,618 |
) |
|
(3,014 |
) |
|
(6,346 |
) |
|
(16,334 |
) |
||||
Loss on sale of |
|
— |
|
|
— |
|
|
(570 |
) |
|
— |
|
||||
Stock-based compensation expense |
|
(36 |
) |
|
(37 |
) |
|
(146 |
) |
|
(102 |
) |
||||
Adjustments to acquired tangible assets (4) |
|
(66 |
) |
|
(121 |
) |
|
(198 |
) |
|
(361 |
) |
||||
Employee related restructuring |
|
— |
|
|
— |
|
|
(204 |
) |
|
— |
|
||||
Adjusted Non-GAAP cost of sales |
|
107,629 |
|
|
147,119 |
|
|
322,257 |
|
|
427,179 |
|
||||
Adjusted Non-GAAP gross profit |
|
$ |
46,063 |
|
|
$ |
53,767 |
|
|
$ |
136,684 |
|
|
$ |
149,790 |
|
|
|
|
|
|
|
|
|
|
||||||||
Gross margin: |
|
|
|
|
|
|
|
|
||||||||
Gross margin - GAAP |
|
28.8 |
% |
|
23.2 |
% |
|
27.3 |
% |
|
20.8 |
% |
||||
Section 301 U.S. tariffs on goods imported from |
|
— |
% |
|
1.8 |
% |
|
0.8 |
% |
|
2.1 |
% |
||||
Stock-based compensation for performance-based warrants |
|
0.1 |
% |
|
0.3 |
% |
|
0.1 |
% |
|
0.2 |
% |
||||
Excess manufacturing overhead and factory transition costs (2) |
|
1.1 |
% |
|
1.4 |
% |
|
1.4 |
% |
|
2.8 |
% |
||||
Loss on sale of |
|
— |
% |
|
— |
% |
|
0.1 |
% |
|
— |
% |
||||
Stock-based compensation expense |
|
0.0 |
% |
|
0.0 |
% |
|
0.0 |
% |
|
0.0 |
% |
||||
Adjustments to acquired tangible assets (4) |
|
0.0 |
% |
|
0.1 |
% |
|
0.0 |
% |
|
0.1 |
% |
||||
Employee related restructuring |
|
— |
% |
|
— |
% |
|
0.1 |
% |
|
— |
% |
||||
Adjusted Non-GAAP gross margin |
|
30.0 |
% |
|
26.8 |
% |
|
29.8 |
% |
|
26.0 |
% |
||||
|
|
|
|
|
|
|
|
|
||||||||
Operating expenses: |
|
|
|
|
|
|
|
|
||||||||
Operating expenses - GAAP |
|
$ |
33,910 |
|
|
$ |
40,352 |
|
|
$ |
100,420 |
|
|
$ |
116,482 |
|
Section 301 U.S. tariffs on goods imported from |
|
— |
|
|
(247 |
) |
|
— |
|
|
(1,786 |
) |
||||
Stock-based compensation expense |
|
(2,224 |
) |
|
(2,490 |
) |
|
(6,708 |
) |
|
(6,615 |
) |
||||
Amortization of acquired intangible assets |
|
(1,232 |
) |
|
(1,398 |
) |
|
(4,023 |
) |
|
(4,200 |
) |
||||
Change in contingent consideration |
|
204 |
|
|
(763 |
) |
|
2,428 |
|
|
(1,769 |
) |
||||
Litigation costs (5) |
|
(1,614 |
) |
|
— |
|
|
(1,614 |
) |
|
— |
|
||||
Employee related restructuring and other costs |
|
— |
|
|
(364 |
) |
|
(287 |
) |
|
(1,385 |
) |
||||
Adjusted Non-GAAP operating expenses |
|
$ |
29,044 |
|
|
$ |
35,090 |
|
|
$ |
90,216 |
|
|
$ |
100,727 |
|
|
||||||||||||||||
|
|
Three Months Ended |
|
Nine Months Ended |
||||||||||||
|
|
2020 |
|
2019 |
|
2020 |
|
2019 |
||||||||
Operating income: |
|
|
|
|
|
|
|
|
||||||||
Operating income - GAAP |
|
$ |
10,246 |
|
$ |
6,127 |
|
$ |
24,752 |
|
$ |
3,864 |
|
|||
Section 301 U.S. tariffs on goods imported from |
|
|
— |
|
|
|
3,652 |
|
|
|
3,523 |
|
|
|
13,052 |
|
Stock-based compensation for performance-based warrants |
|
|
187 |
|
|
|
711 |
|
|
|
525 |
|
|
|
1,381 |
|
Excess manufacturing overhead and factory transition costs (2) |
|
|
1,618 |
|
|
|
3,014 |
|
|
|
6,346 |
|
|
|
16,334 |
|
Loss on sale of |
|
|
— |
|
|
|
— |
|
|
|
570 |
|
|
|
— |
|
Stock-based compensation expense |
|
|
2,260 |
|
|
|
2,527 |
|
|
|
6,854 |
|
|
|
6,717 |
|
Adjustments to acquired tangible assets (4) |
|
|
66 |
|
|
|
121 |
|
|
|
198 |
|
|
|
361 |
|
Amortization of acquired intangible assets |
|
|
1,232 |
|
|
|
1,398 |
|
|
|
4,023 |
|
|
|
4,200 |
|
Change in contingent consideration |
|
|
(204 |
) |
|
|
763 |
|
|
|
(2,428 |
) |
|
|
1,769 |
|
Litigation costs (5) |
|
|
1,614 |
|
|
|
— |
|
|
|
1,614 |
|
|
|
— |
|
Employee related restructuring and other costs |
|
|
— |
|
|
|
364 |
|
|
|
491 |
|
|
|
1,385 |
|
Adjusted Non-GAAP operating income |
|
$ |
17,019 |
|
$ |
18,677 |
|
$ |
46,468 |
|
$ |
49,063 |
|
|||
|
|
|
|
|
|
|
|
|
||||||||
Adjusted pro forma operating income as a percentage of net sales |
|
|
11.1 |
% |
|
|
9.3 |
% |
|
|
10.1 |
% |
|
|
8.5 |
% |
|
|
|
|
|
|
|
|
|
||||||||
Net income (loss): |
|
|
|
|
|
|
|
|
||||||||
Net income (loss) - GAAP |
|
$ |
6,168 |
|
$ |
2,669 |
|
$ |
26,414 |
|
$ |
(3,397 |
) |
|||
Section 301 U.S. tariffs on goods imported from |
|
|
— |
|
|
|
3,652 |
|
|
|
3,523 |
|
|
|
13,052 |
|
Stock-based compensation for performance-based warrants |
|
|
187 |
|
|
|
711 |
|
|
|
525 |
|
|
|
1,381 |
|
Excess manufacturing overhead and factory transition costs (2) |
|
|
1,618 |
|
|
|
3,014 |
|
|
|
6,346 |
|
|
|
16,334 |
|
Loss on sale of |
|
|
— |
|
|
|
— |
|
|
|
570 |
|
|
|
— |
|
Stock-based compensation expense |
|
|
2,260 |
|
|
|
2,527 |
|
|
|
6,854 |
|
|
|
6,717 |
|
Adjustments to acquired tangible assets (4) |
|
|
66 |
|
|
|
121 |
|
|
|
198 |
|
|
|
361 |
|
Amortization of acquired intangible assets |
|
|
1,232 |
|
|
|
1,398 |
|
|
|
4,023 |
|
|
|
4,200 |
|
Change in contingent consideration |
|
|
(204 |
) |
|
|
763 |
|
|
|
(2,428 |
) |
|
|
1,769 |
|
Litigation costs (5) |
|
|
1,614 |
|
|
|
— |
|
|
|
1,614 |
|
|
|
— |
|
Employee related restructuring and other costs |
|
|
— |
|
|
|
364 |
|
|
|
491 |
|
|
|
1,385 |
|
Accrued social insurance adjustment (6) |
|
|
— |
|
|
|
— |
|
|
|
(9,464 |
) |
|
|
— |
|
Foreign currency (gain) loss |
|
|
1,597 |
|
|
|
321 |
|
|
|
1,388 |
|
|
|
670 |
|
Income tax provision on adjustments |
|
|
(1,408 |
) |
|
|
(1,268 |
) |
|
|
(1,483 |
) |
|
|
(6,939 |
) |
Other income tax adjustments (7) |
|
|
— |
|
|
|
— |
|
|
|
(1,303 |
) |
|
|
1,772 |
|
Adjusted Non-GAAP net income |
|
$ |
13,130 |
|
$ |
14,272 |
|
$ |
37,268 |
|
$ |
37,305 |
|
|||
|
|
|
|
|
|
|
|
|
||||||||
Diluted shares used in computing earnings (loss) per share: |
|
|
|
|
|
|
|
|
||||||||
GAAP |
|
|
14,205 |
|
|
|
14,170 |
|
|
|
14,189 |
|
|
|
13,861 |
|
Adjusted Non-GAAP |
|
|
14,205 |
|
|
|
14,170 |
|
|
|
14,189 |
|
|
|
14,049 |
|
|
|
|
|
|
|
|
|
|
||||||||
Diluted earnings (loss) per share: |
|
|
|
|
|
|
|
|
||||||||
Diluted earnings (loss) per share - GAAP |
|
$ |
0.43 |
|
$ |
0.19 |
|
$ |
1.86 |
|
$ |
(0.25 |
) |
|||
Total adjustments |
|
$ |
0.49 |
|
$ |
0.82 |
|
$ |
0.76 |
|
$ |
2.90 |
|
|||
Adjusted Non-GAAP diluted earnings per share |
|
$ |
0.92 |
|
$ |
1.01 |
|
$ |
2.63 |
|
$ |
2.66 |
|
(1) |
|
The nine months ended |
(2) |
|
The nine months ended |
(3) |
|
Consists of the loss recorded on the sale of our |
(4) |
|
Consists of depreciation related to the mark-up from cost to fair value of fixed assets acquired in business combinations. |
(5) |
|
Consists of expenses related to our |
(6) |
|
Consists of the reversal of a social insurance accrual related to our |
(7) |
|
The nine months ended |
View source version on businesswire.com: https://www.businesswire.com/news/home/20201105006094/en/
Investors:
Source: